Moreover, BJIKT did not affect the PD-1/PD-L1 binding affinity (Figure 2G), suggesting that BJIKT exerts antitumor effects by regulating the immune response in the tumor microenvironment, rather than exerting direct cytotoxic effects on CRC cells. This evidence concerns the gene CD274 and neoplasm.